MolNFT v2 · #63989 · protein
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
3FQ9: “Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic…”. X-ray diffraction at 1.35. MolNFT v2 #63989 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3FQ9
- Type
- protein
- Length
- 102 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 1.35
- UniProt
- P01308
Structure
x-ray diffraction · resolution 1.35 · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, C | — | protein | 21 | — | P01308 |
| B, D | — | protein | 30 | — | P01308 |
Compared structures
- 3FQ9 · Design of an insulin analog with enhanced receptor-binding selectivity. rationale… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P01308
- Elsewhere: RCSB PDB 3FQ9 · PDBe 3FQ9 · UniProt P01308
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.